Pioglitazone

• A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental vi… Not authorised
  2024-515642-17-00 Phase II 1 country I.F.O. Istituti Fisioterapici Ospitalieri
• CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) P… Pending
  2024-516328-32-00 Phase II 1 country Centre Hospitalier De Versailles
• “A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental v… Pending
  2025-523266-24-00 Phase II 1 country I.F.O. Istituti Fisioterapici Ospitalieri
• A Study of Tirzepatide Compared with Intensified Conventional Care in Adult Participants with Type 2 Diabetes (SURPASS-EARLY) Recruiting
  2022-501073-40-00 Phase IV 5 countries Eli Lilly & Co.
• Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone… Recruiting
  2024-513416-98-00 Phase II 2 countries Karolinska University Hospital
• SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy Recruiting
  2025-521748-39-00 Phase IV 1 country Universita Cattolica Del Sacro Cuore
• PROMETEO-HG Recruiting
  2024-516561-37-01 Phase III 1 country Consorcio Centro De Investigacion Biomedica En Red
• A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATO Recruiting
  2022-501057-36-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Ended
  2025-520686-46-00 Phase IV 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…
• PIO2STOP_Combination study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia patients after failure of a TKI… Ended
  2024-515460-31-00 Phase II 1 country Centre Hospitalier De Versailles
• Clinical study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient gly… Ended
  2023-508924-36-00 Phase III 1 country Celltrion Inc.
• A research study to see how well new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar… Ended
  2022-502484-38-00 Phase III 3 countries Novo Nordisk A/S
• A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended
  2022-500101-41-00 Phase IV 4 countries Eli Lilly Cork Limited
• A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose comb… Ended
  2024-518527-29-00 Phase II 5 countries Fundacio Sant Joan De Deu

Showing 1–14 of 14 trials